Who Paid My Doc
P3 switching study PK; plaque psoriasis
Research payments
$3,707,943
Through program year 2024, $3,707,943 in research payments was reported against P3 switching study PK; plaque psoriasis, across 87 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $3,225 | 1 |
| 2022 | Research | $3,704,718 | 86 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Todd Schlesinger Charleston, SC Named on 4 payments
- Phoebe Rich Portland, OR Named on 3 payments
- John Tu Rochester, NY Named on 3 payments
- Delilah Alonso South Miami, FL Named on 3 payments
- David Greenstein Beverly, MA Named on 3 payments
- Craig Teller Bellaire, TX Named on 3 payments
- Eduardo Weiss Hollywood, FL Named on 3 payments
- Samuel Lederman Lake Worth, FL Named on 3 payments
- Mark Amster Brighton, MA Named on 3 payments
- James Krell Birmingham, AL Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.